This content is from the "Advancing the Science of Cancer in Latinos: 2024 Conference Proceedings."
Using Science to Address Latino Health Disparities Research
Eliseo J. Pérez-Stable, M.D., is Director of the National Institute on Minority Health and Health Disparities (NIMHD) at the National Institutes of Health (NIH). This plenary session occurred at 8:30 am., Wednesday, Feb. 21, 2024, at the 4th biennial Advancing the Science of Cancer in Latinos conference. Health disparities Dr. Pérez-Stable began his presentation by discussing populations with health disparities. While race, ethnicity, and socioeconomic status are the fundamental pillars of health disparities science, the intersection of these factors with rural populations, sexual and gender minorities, and people ...
This content is from the "Advancing the Science of Cancer in Latinos: 2024 Conference Proceedings."
Designing Food Pantries to Improve Food Security Among Cancer Survivors
Dr. Sandi Pruitt is Associate Professor and Associate Director of Community Outreach, Engagement, and More in the Harold C. Simmons Comprehensive Cancer Center at the University of Texas Southwestern Medical Center. She also serves as Vice Chair of the Board of Directors for Crossroads Community Services. Food security and cancer Dr. Sandi Pruitt’s presentation discussed food security and cancer, best practices and solutions, and a Dallas pantry redesign. The gold standard for measuring food security is the validated US Food and Drug Administration (FDA) survey, which is offered in 6, 10, and 18 question ...
This content is from the "Advancing the Science of Cancer in Latinos: 2024 Conference Proceedings."
Residence in a Latino Enclave and Clinical Outcomes in Texas Children with Acute Lymphoblastic Leukemia
Dr. Jeremy Schraw is an Assistant Professor in the Division of Hematology-Oncology, Department of Pediatrics, at Baylor College of Medicine. Dr. Schraw began by pointing out the higher incidence of acute lymphoblastic leukemia (ALL) among Latino children, and the poorer overall survival (OS) following diagnosis. Social determinants of health likely contribute to these disparities. In fact, children living in Latino enclaves, defined as neighborhoods with a high proportion of Latino residents, recent immigrants, and linguistically isolated households, have poorer OS after diagnosis of ...
This content is from the "Advancing the Science of Cancer in Latinos: 2024 Conference Proceedings."
Cancer Deaths Among Latinos in the COVID-19 Era: National and State Trends
Dr. Rogelio Sáenz is Professor of Sociology and Demography, Dean of the College of Public Policy, and holds the Mark G. Yudof Endowed Chair at the University of Texas at San Antonio. COVID-19 vulnerability Dr. Sáenz’s presentation began by discussing the vulnerability of people with cancer in the COVID-19 era. Over the last four years, a significant amount of research has observed the negative impact of COVID-19 on the survivability of people with cancer, along with rising numbers of cancer incidence and death due to disrupted health care. The growing Latino population is particularly vulnerable, ...
This content is from the "Advancing the Science of Cancer in Latinos: 2024 Conference Proceedings."
Task Force: Latino Researchers Against Cancer
This session occurred at 11:15 a.m., Friday, Feb. 23, 2024, at the 4th biennial Advancing the Science of Cancer in Latinos conference. Dr. Amelie Ramirez is Professor at the University of Texas (UT) San Antonio, Director of the Institute for Health Promotion Research, Chair of the Department of Population Health Sciences at UT Health San Antonio, and Associate Director of Cancer Outreach and Engagement at Mays Cancer Center. Dr. Ramirez’s presentation focused on communicating the mission and first year results of the Task Force: Latino Researchers Against Cancer (TFLRAC). The Task Force’s mission is to meet quarterly for 2 ...
This content is from the "Advancing the Science of Cancer in Latinos: 2024 Conference Proceedings."
Integrating Clinical and Genomic Data for Tumor Molecular Profiling in Latino Patients with Cancer
Dr. Enrique I. Velazquez-Villarreal is Assistant Professor in the Department of Integrative Translational Sciences at Beckman Research Institute and the City of Hope Comprehensive Cancer Center. Multi-omics and colorectal cancer in Latinos Dr. Velazquez-Villarreal’s presentation discussed how multi-omics can be used to understand colorectal cancer disparities in Latino individuals and how global and local ancestry impacts these disparities. He also described clinical and genomic data integration in colorectal cancer disparities and recent technologies used to understand the tumor ...
This content is from the "Advancing the Science of Cancer in Latinos: 2024 Conference Proceedings."
Structural Determinants of Health Impacting Latino Cancer Health Disparities: Genetic Cancer Risk Assessment
Dr. Alejandra Hurtado de Mendoza is an Assistant Professor at the Cancer Prevention and Control Program at Georgetown Lombardi Comprehensive Cancer Center. Disparities across the continuum Dr. Hurtado de Mendoza’s presentation focused on disparities in genetic cancer risk assessment, multi-level barriers that Latinos face across the genetic cancer risk assessment continuum, and an example of a multilevel intervention to decrease disparities. The presentation began by discussing how disparities in the genetic cancer risk assessment continuum begin with awareness. Only ...
This content is from the "Advancing the Science of Cancer in Latinos: 2024 Conference Proceedings."
Latino Cancer Survivors’ Quality of Life and Survivorship Care
Dr. Kristi D. Graves is a tenured Professor of Oncology, Cancer Prevention and Control Program leader at the Lombardi Comprehensive Cancer Center, and Associate Dean for Faculty Development at Georgetown University Medical Center. Latino cancer survivorship Dr. Graves’s presentation began by discussing cancer survivorship across the cancer continuum. The National Cancer Institute’s (NCI) Office of Cancer Survivorship states that “an individual is considered a cancer survivor from the time of diagnosis through the balance of life. There are many types of survivors, including those living with cancer and those ...
This content is from the "Advancing the Science of Cancer in Latinos: 2024 Conference Proceedings."
Adapting NCI’s Clinical Trials System to a Changed Clinical Research Environment
Dr. James H. Doroshow is Deputy Director for Clinical and Translational Research at the National Cancer Institute (NCI). This plenary session occurred at 8:30 am., Thursday, Feb. 22, 2024, at the 4th biennial Advancing the Science of Cancer in Latinos conference. COVID’s impact on cancer clinical trials Dr. Doroshow’s presentation began by discussing the initial and continuing effects of the pandemic environment on cancer clinical trials. From the start of the pandemic, several aspects of clinical trials were altered, including informed consent and in-person study activities. One major ...
